XTX Topco’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.2K Sell
29,202
-76,490
-72% -$56.5K ﹤0.01% 3542
2025
Q4
$75.2K Buy
105,692
+7,854
+8% +$10.7K ﹤0.01% 2720
2025
Q3
$158K Buy
+97,838
New +$98.5K 0.01% 1921
2025
Q1
Sell
-20,687
Closed -$29.6K 3116
2024
Q4
$29.6K Sell
20,687
-28,603
-58% -$64.1K ﹤0.01% 1979
2024
Q3
$95.1K Buy
49,290
+16,687
+51% +$47.1K 0.01% 1614
2024
Q2
$101K Buy
32,603
+1,727
+6% +$7.13K 0.01% 1417
2024
Q1
$161K Buy
+30,876
New +$148K 0.02% 1240
2023
Q4
Sell
-38,954
Closed -$99.3K 2154
2023
Q3
$99.3K Buy
+38,954
New +$163K 0.02% 1187

Other funds holding TNYA

XTX Topco's TNYA Position: Q1 2026 in Review

XTX Topco reduced its Tenaya Therapeutics (TNYA) stake by 72% in Q1 2026, selling an estimated $56.5K and leaving 29,202 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

XTX Topco first reported a position in TNYA in Q3 2023 and has held it in 8 quarters since. The position peaked at $161K in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • XTX Topco held 29,202 shares of Tenaya Therapeutics worth $20.2K as of Q1 2026.
  • XTX Topco sold 76,490 Tenaya Therapeutics shares in Q1 2026, an estimated $56.5K.
  • Tenaya Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3542 holding.
  • XTX Topco first reported a position in Tenaya Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • XTX Topco's Tenaya Therapeutics position peaked at $161K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.